MedRead Journal of Hematology

Analyses Of Blood Diseases and Prohibition

journal scope

The goal of the MedRead Journal of Hematology (MedRead J Hematol) is to offer scientists, researchers, and other Hematology and Current professionals the opportunity to share knowledge of scientific advancements in the myriad disciplines concerning their work, through an honored peer-reviewed publication. The MedRead Journal of Hematology (MedRead J Hematol) serves as an international forum for vital research and developments in hematology and related sciences.

 Journal publishes research articles as a full-length research paper, review articles, case reports, short communications, etc. in innovative formats that target a broad and non-specialized audience in all areas of hematology and related sciences and making them accessible online freely without any restrictions or any other subscriptions to researchers worldwide.

 The field of the journal includes, but is not restricted to:

Haemoglobinuria, Haemoglobinaemia, Hemerythrin, Hemocyanin, Hematocele, Erythropoiesis, Hematological Malignancies, Hematopoiesis, Venipuncture, Venous Blood, Cell Therapy, Blood platelets, Blood Vessels, Leukemia, Myeloma, Red Blood Cells, Blood Tests, White Blood Cells, Blood Components, Blood Cells, Cord Blood, Blood-transfusion, High Blood pressure, etc.

Submission and processing of the manuscripts can be done online into the Editorial Manager System which helps to keep the quality of the peer-review process and presents easy access to the authors to track the status of the manuscript, including evaluation and publication in an automated mode. Subject experts under the guidance of the Editor-in-Chief review the manuscripts. Approval of at least two independent reviewers and the editor is mandatory for the acceptance of the manuscript for publication.